ClinicalTrials.gov
public full text
Public Domain
A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)
This study will determine whether the CT formulation of famotidine taken with and without water is bioequivalent to the FCT formulation. The primary hypothesis is that the area under the concentration-time curve (AUC) and the maximum plasma concentration (Cmax) of a single dose of famotidine 20 mg CT without water are equivalent to a single dose of famotidine 20 mg FCT with water.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions#878044
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered#1228912
- Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions#913422
- A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions#803093
- Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions#890226
Record · ID 1210982
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive